The pathologist's role in sentinel lymph node evaluation

Authors
Citation
Aj. Cochran, The pathologist's role in sentinel lymph node evaluation, SEM NUC MED, 30(1), 2000, pp. 11-17
Citations number
37
Categorie Soggetti
Radiology ,Nuclear Medicine & Imaging
Journal title
SEMINARS IN NUCLEAR MEDICINE
ISSN journal
00012998 → ACNP
Volume
30
Issue
1
Year of publication
2000
Pages
11 - 17
Database
ISI
SICI code
0001-2998(200001)30:1<11:TPRISL>2.0.ZU;2-3
Abstract
Patients with high-risk (thick, deeply invasive) primary melanoma were, in the past, managed by wide local excision and elective node dissection or wi de local excision alone, with subsequent lymphadenectomy if the regional no des developed clinically detectable metastases. We recently developed a mor e logical approach called selective lymph node dissection. To be effective, this requires close collaboration of surgeons, pathologists, and nuclear m edicine physicians. The draining lymph node basin is identified preoperativ ely by lymphoscintigraphy. During surgery, a marker dye (isosulfan blue) an d radioactive technetium labeled albumin are injected intradermally around the primary melanoma and the afferent lymphatics are followed up to the fir st lymph nodes of the ipsilateral regional nodal basin. The surgeon excises the blue-colored and maximally radioactive sentinel nodes and the patholog ist critically evaluates these for the presence of a metastatic tumor. If t he sentinel nodes are tumor free, no further nodal dissection is undertaken ; if a tumor is present, a complete dissection of the nodal basin is perfor med. We have examined 1,119 sentinel lymph nodes from 669 patients treated by selective lymph node dissection. We identified melanoma cells in sentine l nodes from 126 patients (17.8%). A single node contained tumors in 67% of patients, 2 nodes were positive in 25%, and the remaining 12% of patients had three tumor-containing nodes. Melanoma cells were dispersed singly or i n variably sized groups, usually in the peripheral nodal sinus. In around 4 0% of patients, immunohistochemistry is required to identify minute numbers of tumor cells. With experience, pathologists identify tumors in hematoxyl in and eosin (H&E) preparations in an increasing proportion of lymph nodes. Tumor cells are more frequent in the sentinel nodes of patients with prima ry tumors of deeper Clark level and greater Breslow thickness, Tumor cells must be discriminated from capsular nevus cells, interdigitating dendritic leukocytes, macrophages,and intranodal neural tissues. Copyright (C) 2000 b y W.B. Saunders Company.